Difficulty: Medium
Average Score: 92%
Practice
Select the drug of granulocyte colony-stimulating factor:
Correct answer
A
Rationale
In the context of Lifespan Pharmacology, the correct drug of granulocyte colony-stimulating factor is Filgrastim (Option A). Granulocyte colony-stimulating factors are used to stimulate the production of white blood cells, specifically granulocytes, in patients undergoing chemotherapy or with other conditions that suppress the bone marrow.
Filgrastim, a synthetic form of the naturally occurring granulocyte colony-stimulating factor, helps in preventing infections in patients undergoing chemotherapy by boosting their immune system.
Option B, Methotrexate, is an antimetabolite drug used in chemotherapy to treat various types of cancer and autoimmune diseases. It does not have the same mechanism of action as granulocyte colony-stimulating factors.
Option C, Erythropoietin, is a hormone that stimulates red blood cell production and is used to treat anemia. It does not stimulate white blood cell production like granulocyte colony-stimulating factors.
Option D, Doxorubicin, is a chemotherapy drug that works by interfering with the DNA of cancer cells to inhibit their growth. It does not have the same mechanism of action as granulocyte colony-stimulating factors.
Understanding the specific uses and mechanisms of action of different drugs is crucial in pharmacology to ensure safe and effective treatment for patients. In the context of Lifespan Pharmacology, knowing which drug stimulates white blood cell production can help healthcare professionals make informed decisions in managing patients' care, especially those undergoing chemotherapy.
Filgrastim, a synthetic form of the naturally occurring granulocyte colony-stimulating factor, helps in preventing infections in patients undergoing chemotherapy by boosting their immune system.
Option B, Methotrexate, is an antimetabolite drug used in chemotherapy to treat various types of cancer and autoimmune diseases. It does not have the same mechanism of action as granulocyte colony-stimulating factors.
Option C, Erythropoietin, is a hormone that stimulates red blood cell production and is used to treat anemia. It does not stimulate white blood cell production like granulocyte colony-stimulating factors.
Option D, Doxorubicin, is a chemotherapy drug that works by interfering with the DNA of cancer cells to inhibit their growth. It does not have the same mechanism of action as granulocyte colony-stimulating factors.
Understanding the specific uses and mechanisms of action of different drugs is crucial in pharmacology to ensure safe and effective treatment for patients. In the context of Lifespan Pharmacology, knowing which drug stimulates white blood cell production can help healthcare professionals make informed decisions in managing patients' care, especially those undergoing chemotherapy.